Skip to content

Mechanism Study of Computer-Assisted Cognitive Rehabilitation Therapy in lmproving the Cognitive Function of Cancer Patients

Mechanism Study of Computer-Assisted Cognitive Rehabilitation Therapy in lmproving the Cognitive Function of Cancer Patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113914
Enrollment
Unknown
Registered
2025-12-04
Start date
2024-05-27
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer-related cognitive dysfunction

Interventions

Longitudinal investigation group:None
CCRT intervention group:computer-assisted cognitive rehabilitation therapy and Usual care

Sponsors

The First Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Study Sample Cross-sectional study inclusion criteria: Patients with a confirmed cancer diagnosis (head and neck cancers, thoracic cancers, abdominal cancers, brain tumors); aged 18-60 years; able to hear, speak, read, and write; right-handed; previously normal cognitive function; primary school education or higher; voluntary participation; signed informed consent. Longitudinal study inclusion criteria: Patients newly diagnosed with cancer who undergo cognitive function assessments at preoperative, postoperative, and 1, 3, 6, and 12 months after radiation or chemotherapy. Inclusion criteria: Pathologically confirmed cancer via biopsy or intraoperative frozen section (head and neck, thoracic, abdominal cancers); Stage I-II; requiring surgical resection; aged 18-60 years; able to hear, speak, read, and write; right-handed; previously normal cognitive function; primary school education or higher; voluntary participation; signed informed consent. 2. Intervention Sample Inclusion criteria: (1) Patients diagnosed with cancer for the first time within the past 6 months; (2) Currently receiving active anti-cancer treatment (surgery, chemotherapy, radiotherapy); (3) Aged 18-60 years; (4) Junior high school education or higher with normal hearing, speaking, vision, and cognitive abilities, able to understand the information sheet and consent form; (5) Proficient in using smartphones to access the internet at home or work.

Exclusion criteria

Exclusion criteria: 1. Exclusion Criteria for Longitudinal Study (1) Patients with severe suicidal ideation or severe impulsive behavior at present; (2) History of other severe psychiatric disorders; (3) History of alcohol or other substance dependence or abuse; (4) Systematic use of any antipsychotic medication or systematic psychotherapy within the past year. 2. Exclusion Criteria for Intervention Group (1) Patients diagnosed with Stage IV cancer, recurrent metastatic cancer, or hematological malignancies; (2) Patients with severe suicidal ideation or severe impulsive behavior at present; (3) History of other severe psychiatric disorders; (4) History of alcohol or other substance dependence or abuse; (5) Systematic use of any antipsychotic medication or systematic psychotherapy within the past year.

Design outcomes

Primary

MeasureTime frame
Functional Assessment of Cancer Therapy-Cognitive Function, Version 3;functional near-infrared spectroscopy;Hospital Anxiety and Depression Scale;European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Core 30;

Secondary

MeasureTime frame
Edmonton Symptom Assessment Scale;Skin electrophysiological reflex;

Countries

China

Contacts

Public ContactYang Yang

The First Hospital of Shanxi Medical University

yangyang_880914@163.om+86 182 3411 9762

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026